Oncotarget

Research Papers:

A developed model of cancer patients participation in intravenous chemotherapy safety

Zeng Na, Yan Qiaoyuan _, Wang Binghan, Zhu Qin, Chen Yue, Peng Xin, Tan Cuilian and Yao Cheng

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:87598-87606. https://doi.org/10.18632/oncotarget.20986

Metrics: PDF 1618 views  |   HTML 2973 views  |   ?  


Abstract

Zeng Na1, Yan Qiaoyuan2, Wang Binghan2, Zhu Qin3, Chen Yue4, Peng Xin2, Tan Cuilian2 and Yao Cheng5

1College of Medical Science, China Three Gorges University, Yichang 443000, Hubei, China

2Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, China

3School of Nursing, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China

4First Affiliated Hospital, Chongqing Medical University, Yuzhong 400000, Chongqing, China

5Public Health Department, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, China

Correspondence to:

Yan Qiaoyuan, email: [email protected]

Keywords: patient participation, safety, model, intravenous chemotherapy, cancer

Received: July 15, 2017    Accepted: August 27, 2017    Published: September 18, 2017

ABSTRACT

How to reduce intravenous chemotherapy-related adverse reactions of cancer patients is one focus of clinical work. Nowadays, patient for patient safety (PFPS) is an important component of hospital safety management and can contribute to a reduction in the rate of adverse events following intravenous chemotherapy of cancer patients. To guide and evaluate cancer patients participate in intravenous chemotherapy, we explored a scientific and practical model of cancer patients participation in intravenous chemotherapy safety. which can also guide nurse practitioners (NPs) practice. Based on a literature review and analysis of chemotherapy-associated adverse events from two large comprehensive hospitals, combined with the existing strategies for PFPS, the model of cancer patients participation in intravenous chemotherapy safety was drafted. Then we conducted two rounds of the Delphi-method questionnaire to revise the model. The two rounds Delphi questionnaire survey had a response rate of 82.36%. The authoritative coefficient was 0.87 and the coordination coefficients were 0.165 and 0.214, respectively. The proposed safety model included 3 first-order indicators, 8 second-order indicators, and 41 third-order indicators, including content of patients participation, responsibilities of medical personnel to assist cancer patients participation, and suggestions for guaranteeing implementation. Many NPs practice in a medical setting where cancer patients for patient safety behavior are blurred. The model of cancer patients participation in intravenous chemotherapy safety can guide NPs in their practice of promoting PFPS among cancer patients intravenous chemotherapy.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20986